nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—CYP3A4—Rivastigmine—Alzheimer's disease	0.0661	0.432	CbGbCtD
Sirolimus—CYP3A4—Donepezil—Alzheimer's disease	0.0528	0.345	CbGbCtD
Sirolimus—CYP3A4—Galantamine—Alzheimer's disease	0.034	0.223	CbGbCtD
Sirolimus—EIF4E—embryo—Alzheimer's disease	0.0104	0.109	CbGeAlD
Sirolimus—EIF4E—forebrain—Alzheimer's disease	0.00916	0.096	CbGeAlD
Sirolimus—EIF4E—telencephalon—Alzheimer's disease	0.00842	0.0883	CbGeAlD
Sirolimus—Tacrolimus—PPP3CA—Alzheimer's disease	0.00826	0.895	CrCbGaD
Sirolimus—MTOR—blood vessel—Alzheimer's disease	0.00672	0.0704	CbGeAlD
Sirolimus—EIF4E—nervous system—Alzheimer's disease	0.00497	0.0521	CbGeAlD
Sirolimus—EIF4E—central nervous system—Alzheimer's disease	0.00479	0.0502	CbGeAlD
Sirolimus—MTOR—embryo—Alzheimer's disease	0.00401	0.042	CbGeAlD
Sirolimus—EIF4E—brain—Alzheimer's disease	0.0038	0.0398	CbGeAlD
Sirolimus—MTOR—forebrain—Alzheimer's disease	0.00354	0.0372	CbGeAlD
Sirolimus—MTOR—telencephalon—Alzheimer's disease	0.00326	0.0342	CbGeAlD
Sirolimus—FKBP1A—forebrain—Alzheimer's disease	0.00319	0.0334	CbGeAlD
Sirolimus—FKBP1A—telencephalon—Alzheimer's disease	0.00293	0.0307	CbGeAlD
Sirolimus—FGF2—cerebellum—Alzheimer's disease	0.00285	0.0299	CbGeAlD
Sirolimus—FGF2—brain—Alzheimer's disease	0.00232	0.0243	CbGeAlD
Sirolimus—MTOR—nervous system—Alzheimer's disease	0.00192	0.0202	CbGeAlD
Sirolimus—MTOR—central nervous system—Alzheimer's disease	0.00185	0.0194	CbGeAlD
Sirolimus—MTOR—cerebellum—Alzheimer's disease	0.00181	0.019	CbGeAlD
Sirolimus—FKBP1A—nervous system—Alzheimer's disease	0.00173	0.0181	CbGeAlD
Sirolimus—FKBP1A—central nervous system—Alzheimer's disease	0.00167	0.0175	CbGeAlD
Sirolimus—FKBP1A—cerebellum—Alzheimer's disease	0.00163	0.0171	CbGeAlD
Sirolimus—SLC47A1—nervous system—Alzheimer's disease	0.00149	0.0156	CbGeAlD
Sirolimus—MTOR—brain—Alzheimer's disease	0.00147	0.0154	CbGeAlD
Sirolimus—SLC47A1—central nervous system—Alzheimer's disease	0.00143	0.015	CbGeAlD
Sirolimus—SLC47A1—cerebellum—Alzheimer's disease	0.0014	0.0147	CbGeAlD
Sirolimus—ABCB1—blood vessel—Alzheimer's disease	0.0014	0.0147	CbGeAlD
Sirolimus—FKBP1A—brain—Alzheimer's disease	0.00132	0.0139	CbGeAlD
Sirolimus—SLC47A1—brain—Alzheimer's disease	0.00114	0.0119	CbGeAlD
Sirolimus—Temsirolimus—CYP2D6—Alzheimer's disease	0.000968	0.105	CrCbGaD
Sirolimus—ABCB1—embryo—Alzheimer's disease	0.000834	0.00874	CbGeAlD
Sirolimus—ABCB1—forebrain—Alzheimer's disease	0.000737	0.00773	CbGeAlD
Sirolimus—ABCB1—telencephalon—Alzheimer's disease	0.000678	0.00711	CbGeAlD
Sirolimus—CYP3A4—nervous system—Alzheimer's disease	0.000566	0.00593	CbGeAlD
Sirolimus—CYP3A4—central nervous system—Alzheimer's disease	0.000544	0.00571	CbGeAlD
Sirolimus—Hypertension—Galantamine—Alzheimer's disease	0.000502	0.0011	CcSEcCtD
Sirolimus—Haematuria—Memantine—Alzheimer's disease	0.0005	0.00109	CcSEcCtD
Sirolimus—Visual impairment—Donepezil—Alzheimer's disease	0.000499	0.00109	CcSEcCtD
Sirolimus—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000498	0.00109	CcSEcCtD
Sirolimus—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000498	0.00109	CcSEcCtD
Sirolimus—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000496	0.00109	CcSEcCtD
Sirolimus—Chest pain—Galantamine—Alzheimer's disease	0.000495	0.00109	CcSEcCtD
Sirolimus—Arthralgia—Galantamine—Alzheimer's disease	0.000495	0.00109	CcSEcCtD
Sirolimus—Myalgia—Galantamine—Alzheimer's disease	0.000495	0.00109	CcSEcCtD
Sirolimus—Epistaxis—Memantine—Alzheimer's disease	0.000494	0.00108	CcSEcCtD
Sirolimus—Anxiety—Galantamine—Alzheimer's disease	0.000494	0.00108	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000492	0.00108	CcSEcCtD
Sirolimus—Sinusitis—Memantine—Alzheimer's disease	0.000492	0.00108	CcSEcCtD
Sirolimus—Sweating—Rivastigmine—Alzheimer's disease	0.000491	0.00108	CcSEcCtD
Sirolimus—Discomfort—Galantamine—Alzheimer's disease	0.000489	0.00107	CcSEcCtD
Sirolimus—Haematuria—Rivastigmine—Alzheimer's disease	0.000489	0.00107	CcSEcCtD
Sirolimus—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000485	0.00106	CcSEcCtD
Sirolimus—Epistaxis—Rivastigmine—Alzheimer's disease	0.000483	0.00106	CcSEcCtD
Sirolimus—Tinnitus—Donepezil—Alzheimer's disease	0.000483	0.00106	CcSEcCtD
Sirolimus—Sinusitis—Rivastigmine—Alzheimer's disease	0.000481	0.00105	CcSEcCtD
Sirolimus—Confusional state—Galantamine—Alzheimer's disease	0.000479	0.00105	CcSEcCtD
Sirolimus—Haemoglobin—Memantine—Alzheimer's disease	0.000473	0.00104	CcSEcCtD
Sirolimus—Rhinitis—Memantine—Alzheimer's disease	0.000472	0.00103	CcSEcCtD
Sirolimus—Haemorrhage—Memantine—Alzheimer's disease	0.00047	0.00103	CcSEcCtD
Sirolimus—Hallucination—Memantine—Alzheimer's disease	0.000468	0.00103	CcSEcCtD
Sirolimus—Hypoaesthesia—Memantine—Alzheimer's disease	0.000468	0.00103	CcSEcCtD
Sirolimus—Shock—Galantamine—Alzheimer's disease	0.000467	0.00102	CcSEcCtD
Sirolimus—Pharyngitis—Memantine—Alzheimer's disease	0.000467	0.00102	CcSEcCtD
Sirolimus—Nervous system disorder—Galantamine—Alzheimer's disease	0.000466	0.00102	CcSEcCtD
Sirolimus—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000465	0.00102	CcSEcCtD
Sirolimus—Chills—Donepezil—Alzheimer's disease	0.000465	0.00102	CcSEcCtD
Sirolimus—Urinary tract disorder—Memantine—Alzheimer's disease	0.000464	0.00102	CcSEcCtD
Sirolimus—Tachycardia—Galantamine—Alzheimer's disease	0.000463	0.00102	CcSEcCtD
Sirolimus—Oedema peripheral—Memantine—Alzheimer's disease	0.000463	0.00102	CcSEcCtD
Sirolimus—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000462	0.00101	CcSEcCtD
Sirolimus—Connective tissue disorder—Memantine—Alzheimer's disease	0.000462	0.00101	CcSEcCtD
Sirolimus—Rhinitis—Rivastigmine—Alzheimer's disease	0.000461	0.00101	CcSEcCtD
Sirolimus—Skin disorder—Galantamine—Alzheimer's disease	0.000461	0.00101	CcSEcCtD
Sirolimus—Urethral disorder—Memantine—Alzheimer's disease	0.000461	0.00101	CcSEcCtD
Sirolimus—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00046	0.00101	CcSEcCtD
Sirolimus—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000459	0.00101	CcSEcCtD
Sirolimus—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000458	0.001	CcSEcCtD
Sirolimus—Hallucination—Rivastigmine—Alzheimer's disease	0.000458	0.001	CcSEcCtD
Sirolimus—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000457	0.001	CcSEcCtD
Sirolimus—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000454	0.000996	CcSEcCtD
Sirolimus—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000453	0.000993	CcSEcCtD
Sirolimus—Visual impairment—Memantine—Alzheimer's disease	0.000453	0.000993	CcSEcCtD
Sirolimus—Anorexia—Galantamine—Alzheimer's disease	0.000453	0.000992	CcSEcCtD
Sirolimus—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000452	0.000991	CcSEcCtD
Sirolimus—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000451	0.000988	CcSEcCtD
Sirolimus—Malnutrition—Donepezil—Alzheimer's disease	0.000451	0.000988	CcSEcCtD
Sirolimus—Flatulence—Donepezil—Alzheimer's disease	0.000444	0.000974	CcSEcCtD
Sirolimus—Hypotension—Galantamine—Alzheimer's disease	0.000444	0.000972	CcSEcCtD
Sirolimus—Visual impairment—Rivastigmine—Alzheimer's disease	0.000443	0.000972	CcSEcCtD
Sirolimus—Tension—Donepezil—Alzheimer's disease	0.000443	0.00097	CcSEcCtD
Sirolimus—Tinnitus—Memantine—Alzheimer's disease	0.000439	0.000961	CcSEcCtD
Sirolimus—Nervousness—Donepezil—Alzheimer's disease	0.000438	0.00096	CcSEcCtD
Sirolimus—Cardiac disorder—Memantine—Alzheimer's disease	0.000437	0.000956	CcSEcCtD
Sirolimus—Back pain—Donepezil—Alzheimer's disease	0.000436	0.000956	CcSEcCtD
Sirolimus—Muscle spasms—Donepezil—Alzheimer's disease	0.000434	0.00095	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000433	0.000948	CcSEcCtD
Sirolimus—Insomnia—Galantamine—Alzheimer's disease	0.00043	0.000941	CcSEcCtD
Sirolimus—Tinnitus—Rivastigmine—Alzheimer's disease	0.000429	0.00094	CcSEcCtD
Sirolimus—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000427	0.000936	CcSEcCtD
Sirolimus—Angiopathy—Memantine—Alzheimer's disease	0.000427	0.000935	CcSEcCtD
Sirolimus—Paraesthesia—Galantamine—Alzheimer's disease	0.000426	0.000934	CcSEcCtD
Sirolimus—Immune system disorder—Memantine—Alzheimer's disease	0.000425	0.000931	CcSEcCtD
Sirolimus—Mediastinal disorder—Memantine—Alzheimer's disease	0.000424	0.000929	CcSEcCtD
Sirolimus—Tremor—Donepezil—Alzheimer's disease	0.000422	0.000926	CcSEcCtD
Sirolimus—Somnolence—Galantamine—Alzheimer's disease	0.000422	0.000925	CcSEcCtD
Sirolimus—Chills—Memantine—Alzheimer's disease	0.000422	0.000925	CcSEcCtD
Sirolimus—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000418	0.000917	CcSEcCtD
Sirolimus—Dyspepsia—Galantamine—Alzheimer's disease	0.000418	0.000916	CcSEcCtD
Sirolimus—Angiopathy—Rivastigmine—Alzheimer's disease	0.000417	0.000915	CcSEcCtD
Sirolimus—Anaemia—Donepezil—Alzheimer's disease	0.000417	0.000913	CcSEcCtD
Sirolimus—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000415	0.000909	CcSEcCtD
Sirolimus—Agitation—Donepezil—Alzheimer's disease	0.000414	0.000908	CcSEcCtD
Sirolimus—Chills—Rivastigmine—Alzheimer's disease	0.000413	0.000905	CcSEcCtD
Sirolimus—Decreased appetite—Galantamine—Alzheimer's disease	0.000413	0.000904	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00041	0.000898	CcSEcCtD
Sirolimus—Malnutrition—Memantine—Alzheimer's disease	0.000409	0.000897	CcSEcCtD
Sirolimus—Malaise—Donepezil—Alzheimer's disease	0.000407	0.000891	CcSEcCtD
Sirolimus—Constipation—Galantamine—Alzheimer's disease	0.000406	0.00089	CcSEcCtD
Sirolimus—Syncope—Donepezil—Alzheimer's disease	0.000404	0.000886	CcSEcCtD
Sirolimus—Flatulence—Memantine—Alzheimer's disease	0.000403	0.000884	CcSEcCtD
Sirolimus—Tension—Memantine—Alzheimer's disease	0.000402	0.00088	CcSEcCtD
Sirolimus—Malnutrition—Rivastigmine—Alzheimer's disease	0.000401	0.000878	CcSEcCtD
Sirolimus—ABCB1—nervous system—Alzheimer's disease	0.0004	0.0042	CbGeAlD
Sirolimus—Nervousness—Memantine—Alzheimer's disease	0.000398	0.000871	CcSEcCtD
Sirolimus—Loss of consciousness—Donepezil—Alzheimer's disease	0.000396	0.000868	CcSEcCtD
Sirolimus—Back pain—Memantine—Alzheimer's disease	0.000396	0.000868	CcSEcCtD
Sirolimus—Flatulence—Rivastigmine—Alzheimer's disease	0.000395	0.000865	CcSEcCtD
Sirolimus—Cough—Donepezil—Alzheimer's disease	0.000394	0.000862	CcSEcCtD
Sirolimus—Tension—Rivastigmine—Alzheimer's disease	0.000393	0.000861	CcSEcCtD
Sirolimus—Feeling abnormal—Galantamine—Alzheimer's disease	0.000391	0.000857	CcSEcCtD
Sirolimus—Hypertension—Donepezil—Alzheimer's disease	0.000389	0.000853	CcSEcCtD
Sirolimus—Nervousness—Rivastigmine—Alzheimer's disease	0.000389	0.000852	CcSEcCtD
Sirolimus—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000388	0.000851	CcSEcCtD
Sirolimus—Back pain—Rivastigmine—Alzheimer's disease	0.000387	0.000849	CcSEcCtD
Sirolimus—ABCB1—central nervous system—Alzheimer's disease	0.000385	0.00404	CbGeAlD
Sirolimus—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000385	0.000844	CcSEcCtD
Sirolimus—Myalgia—Donepezil—Alzheimer's disease	0.000384	0.000841	CcSEcCtD
Sirolimus—Chest pain—Donepezil—Alzheimer's disease	0.000384	0.000841	CcSEcCtD
Sirolimus—Arthralgia—Donepezil—Alzheimer's disease	0.000384	0.000841	CcSEcCtD
Sirolimus—Tremor—Memantine—Alzheimer's disease	0.000384	0.00084	CcSEcCtD
Sirolimus—Anxiety—Donepezil—Alzheimer's disease	0.000383	0.000838	CcSEcCtD
Sirolimus—Ill-defined disorder—Memantine—Alzheimer's disease	0.00038	0.000832	CcSEcCtD
Sirolimus—Discomfort—Donepezil—Alzheimer's disease	0.000379	0.000831	CcSEcCtD
Sirolimus—Anaemia—Memantine—Alzheimer's disease	0.000378	0.000829	CcSEcCtD
Sirolimus—ABCB1—cerebellum—Alzheimer's disease	0.000377	0.00395	CbGeAlD
Sirolimus—Agitation—Memantine—Alzheimer's disease	0.000376	0.000824	CcSEcCtD
Sirolimus—Abdominal pain—Galantamine—Alzheimer's disease	0.000375	0.000823	CcSEcCtD
Sirolimus—Body temperature increased—Galantamine—Alzheimer's disease	0.000375	0.000823	CcSEcCtD
Sirolimus—Tremor—Rivastigmine—Alzheimer's disease	0.000375	0.000822	CcSEcCtD
Sirolimus—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000372	0.000814	CcSEcCtD
Sirolimus—Confusional state—Donepezil—Alzheimer's disease	0.000371	0.000813	CcSEcCtD
Sirolimus—Anaemia—Rivastigmine—Alzheimer's disease	0.00037	0.000811	CcSEcCtD
Sirolimus—Malaise—Memantine—Alzheimer's disease	0.000369	0.000809	CcSEcCtD
Sirolimus—Agitation—Rivastigmine—Alzheimer's disease	0.000368	0.000807	CcSEcCtD
Sirolimus—Oedema—Donepezil—Alzheimer's disease	0.000368	0.000806	CcSEcCtD
Sirolimus—Syncope—Memantine—Alzheimer's disease	0.000367	0.000805	CcSEcCtD
Sirolimus—Leukopenia—Memantine—Alzheimer's disease	0.000367	0.000803	CcSEcCtD
Sirolimus—Infection—Donepezil—Alzheimer's disease	0.000366	0.000801	CcSEcCtD
Sirolimus—Shock—Donepezil—Alzheimer's disease	0.000362	0.000793	CcSEcCtD
Sirolimus—Palpitations—Memantine—Alzheimer's disease	0.000362	0.000793	CcSEcCtD
Sirolimus—Malaise—Rivastigmine—Alzheimer's disease	0.000361	0.000791	CcSEcCtD
Sirolimus—Nervous system disorder—Donepezil—Alzheimer's disease	0.000361	0.000791	CcSEcCtD
Sirolimus—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00036	0.00079	CcSEcCtD
Sirolimus—Loss of consciousness—Memantine—Alzheimer's disease	0.00036	0.000788	CcSEcCtD
Sirolimus—Syncope—Rivastigmine—Alzheimer's disease	0.000359	0.000787	CcSEcCtD
Sirolimus—Cough—Memantine—Alzheimer's disease	0.000357	0.000783	CcSEcCtD
Sirolimus—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000356	0.00078	CcSEcCtD
Sirolimus—Palpitations—Rivastigmine—Alzheimer's disease	0.000354	0.000776	CcSEcCtD
Sirolimus—Hypertension—Memantine—Alzheimer's disease	0.000353	0.000775	CcSEcCtD
Sirolimus—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000352	0.000771	CcSEcCtD
Sirolimus—Anorexia—Donepezil—Alzheimer's disease	0.000351	0.000769	CcSEcCtD
Sirolimus—Hypersensitivity—Galantamine—Alzheimer's disease	0.00035	0.000767	CcSEcCtD
Sirolimus—Cough—Rivastigmine—Alzheimer's disease	0.00035	0.000766	CcSEcCtD
Sirolimus—Arthralgia—Memantine—Alzheimer's disease	0.000349	0.000764	CcSEcCtD
Sirolimus—Chest pain—Memantine—Alzheimer's disease	0.000349	0.000764	CcSEcCtD
Sirolimus—Myalgia—Memantine—Alzheimer's disease	0.000349	0.000764	CcSEcCtD
Sirolimus—Anxiety—Memantine—Alzheimer's disease	0.000347	0.000761	CcSEcCtD
Sirolimus—Hypertension—Rivastigmine—Alzheimer's disease	0.000346	0.000758	CcSEcCtD
Sirolimus—Discomfort—Memantine—Alzheimer's disease	0.000344	0.000755	CcSEcCtD
Sirolimus—Hypotension—Donepezil—Alzheimer's disease	0.000344	0.000753	CcSEcCtD
Sirolimus—Arthralgia—Rivastigmine—Alzheimer's disease	0.000341	0.000747	CcSEcCtD
Sirolimus—Chest pain—Rivastigmine—Alzheimer's disease	0.000341	0.000747	CcSEcCtD
Sirolimus—Myalgia—Rivastigmine—Alzheimer's disease	0.000341	0.000747	CcSEcCtD
Sirolimus—Asthenia—Galantamine—Alzheimer's disease	0.000341	0.000747	CcSEcCtD
Sirolimus—Anxiety—Rivastigmine—Alzheimer's disease	0.00034	0.000745	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000339	0.000742	CcSEcCtD
Sirolimus—Confusional state—Memantine—Alzheimer's disease	0.000337	0.000738	CcSEcCtD
Sirolimus—Discomfort—Rivastigmine—Alzheimer's disease	0.000337	0.000738	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000335	0.000735	CcSEcCtD
Sirolimus—Oedema—Memantine—Alzheimer's disease	0.000334	0.000732	CcSEcCtD
Sirolimus—Insomnia—Donepezil—Alzheimer's disease	0.000333	0.000729	CcSEcCtD
Sirolimus—Infection—Memantine—Alzheimer's disease	0.000332	0.000727	CcSEcCtD
Sirolimus—Paraesthesia—Donepezil—Alzheimer's disease	0.00033	0.000724	CcSEcCtD
Sirolimus—Confusional state—Rivastigmine—Alzheimer's disease	0.00033	0.000722	CcSEcCtD
Sirolimus—Shock—Memantine—Alzheimer's disease	0.000329	0.00072	CcSEcCtD
Sirolimus—Dyspnoea—Donepezil—Alzheimer's disease	0.000328	0.000719	CcSEcCtD
Sirolimus—Nervous system disorder—Memantine—Alzheimer's disease	0.000328	0.000718	CcSEcCtD
Sirolimus—Somnolence—Donepezil—Alzheimer's disease	0.000327	0.000717	CcSEcCtD
Sirolimus—Thrombocytopenia—Memantine—Alzheimer's disease	0.000327	0.000717	CcSEcCtD
Sirolimus—Oedema—Rivastigmine—Alzheimer's disease	0.000327	0.000716	CcSEcCtD
Sirolimus—Tachycardia—Memantine—Alzheimer's disease	0.000326	0.000715	CcSEcCtD
Sirolimus—Diarrhoea—Galantamine—Alzheimer's disease	0.000325	0.000712	CcSEcCtD
Sirolimus—Infection—Rivastigmine—Alzheimer's disease	0.000325	0.000712	CcSEcCtD
Sirolimus—Skin disorder—Memantine—Alzheimer's disease	0.000325	0.000711	CcSEcCtD
Sirolimus—Dyspepsia—Donepezil—Alzheimer's disease	0.000324	0.00071	CcSEcCtD
Sirolimus—Hyperhidrosis—Memantine—Alzheimer's disease	0.000323	0.000708	CcSEcCtD
Sirolimus—Shock—Rivastigmine—Alzheimer's disease	0.000322	0.000705	CcSEcCtD
Sirolimus—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000321	0.000702	CcSEcCtD
Sirolimus—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00032	0.000701	CcSEcCtD
Sirolimus—Decreased appetite—Donepezil—Alzheimer's disease	0.00032	0.000701	CcSEcCtD
Sirolimus—Tachycardia—Rivastigmine—Alzheimer's disease	0.000319	0.000699	CcSEcCtD
Sirolimus—Anorexia—Memantine—Alzheimer's disease	0.000319	0.000698	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000318	0.000696	CcSEcCtD
Sirolimus—Skin disorder—Rivastigmine—Alzheimer's disease	0.000318	0.000696	CcSEcCtD
Sirolimus—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000316	0.000692	CcSEcCtD
Sirolimus—Pain—Donepezil—Alzheimer's disease	0.000315	0.00069	CcSEcCtD
Sirolimus—Constipation—Donepezil—Alzheimer's disease	0.000315	0.00069	CcSEcCtD
Sirolimus—Dizziness—Galantamine—Alzheimer's disease	0.000314	0.000688	CcSEcCtD
Sirolimus—Hypotension—Memantine—Alzheimer's disease	0.000312	0.000684	CcSEcCtD
Sirolimus—Anorexia—Rivastigmine—Alzheimer's disease	0.000312	0.000683	CcSEcCtD
Sirolimus—ABCB1—brain—Alzheimer's disease	0.000306	0.00321	CbGeAlD
Sirolimus—Hypotension—Rivastigmine—Alzheimer's disease	0.000305	0.000669	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000304	0.000667	CcSEcCtD
Sirolimus—Feeling abnormal—Donepezil—Alzheimer's disease	0.000303	0.000664	CcSEcCtD
Sirolimus—Insomnia—Memantine—Alzheimer's disease	0.000302	0.000662	CcSEcCtD
Sirolimus—Vomiting—Galantamine—Alzheimer's disease	0.000302	0.000662	CcSEcCtD
Sirolimus—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000301	0.000659	CcSEcCtD
Sirolimus—Paraesthesia—Memantine—Alzheimer's disease	0.0003	0.000657	CcSEcCtD
Sirolimus—Rash—Galantamine—Alzheimer's disease	0.000299	0.000656	CcSEcCtD
Sirolimus—Dermatitis—Galantamine—Alzheimer's disease	0.000299	0.000655	CcSEcCtD
Sirolimus—Dyspnoea—Memantine—Alzheimer's disease	0.000298	0.000653	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000298	0.000653	CcSEcCtD
Sirolimus—Headache—Galantamine—Alzheimer's disease	0.000297	0.000652	CcSEcCtD
Sirolimus—Somnolence—Memantine—Alzheimer's disease	0.000297	0.000651	CcSEcCtD
Sirolimus—Insomnia—Rivastigmine—Alzheimer's disease	0.000296	0.000648	CcSEcCtD
Sirolimus—Dyspepsia—Memantine—Alzheimer's disease	0.000294	0.000644	CcSEcCtD
Sirolimus—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000294	0.000643	CcSEcCtD
Sirolimus—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000291	0.000639	CcSEcCtD
Sirolimus—Abdominal pain—Donepezil—Alzheimer's disease	0.000291	0.000637	CcSEcCtD
Sirolimus—Body temperature increased—Donepezil—Alzheimer's disease	0.000291	0.000637	CcSEcCtD
Sirolimus—Somnolence—Rivastigmine—Alzheimer's disease	0.000291	0.000637	CcSEcCtD
Sirolimus—Decreased appetite—Memantine—Alzheimer's disease	0.00029	0.000636	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000288	0.000632	CcSEcCtD
Sirolimus—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000288	0.00063	CcSEcCtD
Sirolimus—Constipation—Memantine—Alzheimer's disease	0.000286	0.000626	CcSEcCtD
Sirolimus—Pain—Memantine—Alzheimer's disease	0.000286	0.000626	CcSEcCtD
Sirolimus—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000284	0.000623	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000282	0.000618	CcSEcCtD
Sirolimus—Nausea—Galantamine—Alzheimer's disease	0.000282	0.000618	CcSEcCtD
Sirolimus—Pain—Rivastigmine—Alzheimer's disease	0.00028	0.000613	CcSEcCtD
Sirolimus—Constipation—Rivastigmine—Alzheimer's disease	0.00028	0.000613	CcSEcCtD
Sirolimus—Feeling abnormal—Memantine—Alzheimer's disease	0.000275	0.000603	CcSEcCtD
Sirolimus—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000273	0.000599	CcSEcCtD
Sirolimus—Hypersensitivity—Donepezil—Alzheimer's disease	0.000271	0.000594	CcSEcCtD
Sirolimus—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000269	0.00059	CcSEcCtD
Sirolimus—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000267	0.000586	CcSEcCtD
Sirolimus—Body temperature increased—Memantine—Alzheimer's disease	0.000264	0.000579	CcSEcCtD
Sirolimus—Abdominal pain—Memantine—Alzheimer's disease	0.000264	0.000579	CcSEcCtD
Sirolimus—Asthenia—Donepezil—Alzheimer's disease	0.000264	0.000579	CcSEcCtD
Sirolimus—Pruritus—Donepezil—Alzheimer's disease	0.00026	0.000571	CcSEcCtD
Sirolimus—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000258	0.000566	CcSEcCtD
Sirolimus—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000258	0.000566	CcSEcCtD
Sirolimus—Diarrhoea—Donepezil—Alzheimer's disease	0.000252	0.000552	CcSEcCtD
Sirolimus—Hypersensitivity—Memantine—Alzheimer's disease	0.000246	0.000539	CcSEcCtD
Sirolimus—Dizziness—Donepezil—Alzheimer's disease	0.000243	0.000533	CcSEcCtD
Sirolimus—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000241	0.000528	CcSEcCtD
Sirolimus—Asthenia—Memantine—Alzheimer's disease	0.00024	0.000525	CcSEcCtD
Sirolimus—Pruritus—Memantine—Alzheimer's disease	0.000236	0.000518	CcSEcCtD
Sirolimus—Asthenia—Rivastigmine—Alzheimer's disease	0.000235	0.000514	CcSEcCtD
Sirolimus—Vomiting—Donepezil—Alzheimer's disease	0.000234	0.000513	CcSEcCtD
Sirolimus—Rash—Donepezil—Alzheimer's disease	0.000232	0.000508	CcSEcCtD
Sirolimus—Dermatitis—Donepezil—Alzheimer's disease	0.000232	0.000508	CcSEcCtD
Sirolimus—Pruritus—Rivastigmine—Alzheimer's disease	0.000231	0.000507	CcSEcCtD
Sirolimus—Headache—Donepezil—Alzheimer's disease	0.000231	0.000505	CcSEcCtD
Sirolimus—Diarrhoea—Memantine—Alzheimer's disease	0.000229	0.000501	CcSEcCtD
Sirolimus—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000224	0.00049	CcSEcCtD
Sirolimus—Dizziness—Memantine—Alzheimer's disease	0.000221	0.000484	CcSEcCtD
Sirolimus—Nausea—Donepezil—Alzheimer's disease	0.000219	0.000479	CcSEcCtD
Sirolimus—Dizziness—Rivastigmine—Alzheimer's disease	0.000216	0.000474	CcSEcCtD
Sirolimus—Vomiting—Memantine—Alzheimer's disease	0.000212	0.000466	CcSEcCtD
Sirolimus—Rash—Memantine—Alzheimer's disease	0.000211	0.000462	CcSEcCtD
Sirolimus—Dermatitis—Memantine—Alzheimer's disease	0.00021	0.000461	CcSEcCtD
Sirolimus—Headache—Memantine—Alzheimer's disease	0.000209	0.000459	CcSEcCtD
Sirolimus—Vomiting—Rivastigmine—Alzheimer's disease	0.000208	0.000455	CcSEcCtD
Sirolimus—Rash—Rivastigmine—Alzheimer's disease	0.000206	0.000452	CcSEcCtD
Sirolimus—Dermatitis—Rivastigmine—Alzheimer's disease	0.000206	0.000451	CcSEcCtD
Sirolimus—Headache—Rivastigmine—Alzheimer's disease	0.000205	0.000449	CcSEcCtD
Sirolimus—Nausea—Memantine—Alzheimer's disease	0.000198	0.000435	CcSEcCtD
Sirolimus—Nausea—Rivastigmine—Alzheimer's disease	0.000194	0.000425	CcSEcCtD
Sirolimus—MTOR—Signaling Pathways—APP—Alzheimer's disease	2.26e-05	7.9e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PRKCG—Alzheimer's disease	2.25e-05	7.88e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	2.25e-05	7.87e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—CREB1—Alzheimer's disease	2.25e-05	7.86e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—INS—Alzheimer's disease	2.24e-05	7.82e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.23e-05	7.8e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.2e-05	7.69e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PLCB1—Alzheimer's disease	2.19e-05	7.67e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—MAOB—Alzheimer's disease	2.19e-05	7.65e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—LPL—Alzheimer's disease	2.19e-05	7.64e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—AKT1—Alzheimer's disease	2.18e-05	7.62e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.17e-05	7.6e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MEF2C—Alzheimer's disease	2.17e-05	7.57e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.15e-05	7.52e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CCR5—Alzheimer's disease	2.13e-05	7.46e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—BCHE—Alzheimer's disease	2.13e-05	7.46e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PLCB1—Alzheimer's disease	2.13e-05	7.46e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ABCA1—Alzheimer's disease	2.13e-05	7.43e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PRKCG—Alzheimer's disease	2.13e-05	7.43e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—MAPK8—Alzheimer's disease	2.11e-05	7.38e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CALM1—Alzheimer's disease	2.11e-05	7.38e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	2.11e-05	7.37e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CASP3—Alzheimer's disease	2.1e-05	7.33e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.09e-05	7.32e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—MTHFR—Alzheimer's disease	2.09e-05	7.29e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CREB1—Alzheimer's disease	2.08e-05	7.26e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NGF—Alzheimer's disease	2.07e-05	7.24e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—INS—Alzheimer's disease	2.07e-05	7.22e-05	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—IL6—Alzheimer's disease	2.06e-05	7.19e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—BCL2—Alzheimer's disease	2.04e-05	7.15e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.04e-05	7.14e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—A2M—Alzheimer's disease	2.03e-05	7.11e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCL2—Alzheimer's disease	2.03e-05	7.11e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.03e-05	7.1e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCR5—Alzheimer's disease	2.01e-05	7.04e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	2.01e-05	7.04e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IGF1—Alzheimer's disease	2e-05	6.99e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NGFR—Alzheimer's disease	1.99e-05	6.96e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—HTR2A—Alzheimer's disease	1.97e-05	6.89e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS3—Alzheimer's disease	1.96e-05	6.85e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	1.95e-05	6.82e-05	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.95e-05	6.82e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CALM1—Alzheimer's disease	1.95e-05	6.81e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ADAM10—Alzheimer's disease	1.94e-05	6.8e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—APOE—Alzheimer's disease	1.94e-05	6.79e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.94e-05	6.77e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MAPK8—Alzheimer's disease	1.93e-05	6.74e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CAV1—Alzheimer's disease	1.92e-05	6.73e-05	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL6—Alzheimer's disease	1.9e-05	6.65e-05	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—AKT1—Alzheimer's disease	1.9e-05	6.63e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.86e-05	6.52e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.85e-05	6.46e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CALM1—Alzheimer's disease	1.84e-05	6.43e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—S100B—Alzheimer's disease	1.84e-05	6.43e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PPARGC1A—Alzheimer's disease	1.83e-05	6.41e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—LEP—Alzheimer's disease	1.83e-05	6.41e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—APOE—Alzheimer's disease	1.83e-05	6.41e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—HMOX1—Alzheimer's disease	1.82e-05	6.38e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—GSK3B—Alzheimer's disease	1.82e-05	6.37e-05	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—IL6—Alzheimer's disease	1.82e-05	6.35e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CAV1—Alzheimer's disease	1.82e-05	6.35e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NOS3—Alzheimer's disease	1.81e-05	6.33e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS2—Alzheimer's disease	1.81e-05	6.33e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CREB1—Alzheimer's disease	1.81e-05	6.32e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1B—Alzheimer's disease	1.81e-05	6.32e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—Alzheimer's disease	1.79e-05	6.27e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOTCH1—Alzheimer's disease	1.79e-05	6.27e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—VEGFA—Alzheimer's disease	1.78e-05	6.22e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.77e-05	6.19e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ACHE—Alzheimer's disease	1.77e-05	6.19e-05	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—AKT1—Alzheimer's disease	1.76e-05	6.14e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IGF2—Alzheimer's disease	1.75e-05	6.12e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	1.75e-05	6.12e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—ESR1—Alzheimer's disease	1.75e-05	6.12e-05	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—AKT1—Alzheimer's disease	1.75e-05	6.1e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.74e-05	6.09e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—F2—Alzheimer's disease	1.73e-05	6.04e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.72e-05	6.02e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.72e-05	6.02e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFB1—Alzheimer's disease	1.71e-05	5.98e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.71e-05	5.96e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IGF1R—Alzheimer's disease	1.69e-05	5.92e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.69e-05	5.91e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	1.68e-05	5.88e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—GSK3B—Alzheimer's disease	1.68e-05	5.88e-05	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—AKT1—Alzheimer's disease	1.68e-05	5.86e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	1.67e-05	5.85e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—LPL—Alzheimer's disease	1.67e-05	5.83e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CREB1—Alzheimer's disease	1.67e-05	5.83e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ENO1—Alzheimer's disease	1.66e-05	5.8e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	1.66e-05	5.8e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—INS—Alzheimer's disease	1.66e-05	5.8e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—MAPK8—Alzheimer's disease	1.66e-05	5.79e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—MAOB—Alzheimer's disease	1.65e-05	5.78e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.65e-05	5.76e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TGFB1—Alzheimer's disease	1.63e-05	5.71e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	1.63e-05	5.69e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—LPL—Alzheimer's disease	1.62e-05	5.67e-05	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—AKT1—Alzheimer's disease	1.61e-05	5.63e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MEF2C—Alzheimer's disease	1.61e-05	5.62e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.59e-05	5.56e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—GSK3B—Alzheimer's disease	1.59e-05	5.55e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PRKCG—Alzheimer's disease	1.58e-05	5.51e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CREB1—Alzheimer's disease	1.57e-05	5.5e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—INS—Alzheimer's disease	1.57e-05	5.47e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—BCHE—Alzheimer's disease	1.54e-05	5.39e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCL2—Alzheimer's disease	1.54e-05	5.38e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CASP3—Alzheimer's disease	1.54e-05	5.38e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NGF—Alzheimer's disease	1.54e-05	5.37e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—A2M—Alzheimer's disease	1.54e-05	5.37e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.54e-05	5.37e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—LPL—Alzheimer's disease	1.53e-05	5.35e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—BCL2—Alzheimer's disease	1.52e-05	5.3e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IGF1—Alzheimer's disease	1.51e-05	5.29e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—MTHFR—Alzheimer's disease	1.5e-05	5.25e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCR5—Alzheimer's disease	1.49e-05	5.23e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HTR2A—Alzheimer's disease	1.46e-05	5.11e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	1.46e-05	5.09e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS3—Alzheimer's disease	1.45e-05	5.09e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.41e-05	4.94e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	1.41e-05	4.93e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CALM1—Alzheimer's disease	1.4e-05	4.91e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—APOE—Alzheimer's disease	1.4e-05	4.89e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CAV1—Alzheimer's disease	1.39e-05	4.84e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	1.38e-05	4.82e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NOS3—Alzheimer's disease	1.37e-05	4.8e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CALM1—Alzheimer's disease	1.36e-05	4.77e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—APOE—Alzheimer's disease	1.36e-05	4.75e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—LEP—Alzheimer's disease	1.36e-05	4.75e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—IL6—Alzheimer's disease	1.35e-05	4.71e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CAV1—Alzheimer's disease	1.35e-05	4.71e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TP53—Alzheimer's disease	1.34e-05	4.7e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1B—Alzheimer's disease	1.34e-05	4.69e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.34e-05	4.67e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—Alzheimer's disease	1.33e-05	4.65e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.32e-05	4.62e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.3e-05	4.56e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ESR1—Alzheimer's disease	1.3e-05	4.54e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.3e-05	4.53e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFB1—Alzheimer's disease	1.3e-05	4.53e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—IL6—Alzheimer's disease	1.29e-05	4.51e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CALM1—Alzheimer's disease	1.29e-05	4.5e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—APOE—Alzheimer's disease	1.28e-05	4.49e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—F2—Alzheimer's disease	1.28e-05	4.48e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CAV1—Alzheimer's disease	1.27e-05	4.45e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NOTCH1—Alzheimer's disease	1.25e-05	4.39e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.25e-05	4.38e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.25e-05	4.38e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—AKT1—Alzheimer's disease	1.24e-05	4.35e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL6—Alzheimer's disease	1.23e-05	4.3e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—MAPK8—Alzheimer's disease	1.23e-05	4.3e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.23e-05	4.29e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PPARG—Alzheimer's disease	1.22e-05	4.26e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	1.22e-05	4.25e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	1.21e-05	4.23e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.2e-05	4.19e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—INS—Alzheimer's disease	1.19e-05	4.18e-05	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—AKT1—Alzheimer's disease	1.19e-05	4.18e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—AKT1—Alzheimer's disease	1.19e-05	4.16e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—GSK3B—Alzheimer's disease	1.18e-05	4.12e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CREB1—Alzheimer's disease	1.17e-05	4.08e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CASP3—Alzheimer's disease	1.17e-05	4.07e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.16e-05	4.07e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—INS—Alzheimer's disease	1.16e-05	4.06e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL2—Alzheimer's disease	1.14e-05	4e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—AKT1—Alzheimer's disease	1.14e-05	3.97e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IGF1—Alzheimer's disease	1.12e-05	3.93e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PPARG—Alzheimer's disease	1.12e-05	3.91e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—LPL—Alzheimer's disease	1.11e-05	3.87e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.1e-05	3.84e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—INS—Alzheimer's disease	1.1e-05	3.83e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MAPK8—Alzheimer's disease	1.07e-05	3.74e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.06e-05	3.72e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.06e-05	3.71e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.06e-05	3.71e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6—Alzheimer's disease	1.06e-05	3.7e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—NOS3—Alzheimer's disease	1.05e-05	3.66e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NOS3—Alzheimer's disease	1.02e-05	3.56e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.02e-05	3.56e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	9.97e-06	3.48e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—VEGFA—Alzheimer's disease	9.89e-06	3.46e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TP53—Alzheimer's disease	9.86e-06	3.45e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	9.8e-06	3.42e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6—Alzheimer's disease	9.77e-06	3.42e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—AKT1—Alzheimer's disease	9.76e-06	3.41e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFB1—Alzheimer's disease	9.62e-06	3.36e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—NOS3—Alzheimer's disease	9.62e-06	3.36e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—Alzheimer's disease	9.58e-06	3.35e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—A2M—Alzheimer's disease	9.46e-06	3.31e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CALM1—Alzheimer's disease	9.31e-06	3.26e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—APOE—Alzheimer's disease	9.28e-06	3.24e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CAV1—Alzheimer's disease	9.19e-06	3.21e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	9.17e-06	3.21e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—HMOX1—Alzheimer's disease	9.13e-06	3.19e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFB1—Alzheimer's disease	9.08e-06	3.17e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6—Alzheimer's disease	9.03e-06	3.16e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—AKT1—Alzheimer's disease	9.01e-06	3.15e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	8.79e-06	3.07e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CASP3—Alzheimer's disease	8.65e-06	3.02e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—LPL—Alzheimer's disease	8.35e-06	2.92e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—AKT1—Alzheimer's disease	8.33e-06	2.91e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ACHE—Alzheimer's disease	8.23e-06	2.88e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	8.14e-06	2.84e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PPARG—Alzheimer's disease	8.08e-06	2.83e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MAPK8—Alzheimer's disease	7.95e-06	2.78e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—INS—Alzheimer's disease	7.93e-06	2.77e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6—Alzheimer's disease	7.85e-06	2.74e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	7.71e-06	2.7e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ENO1—Alzheimer's disease	7.71e-06	2.7e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	7.56e-06	2.64e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—MTHFR—Alzheimer's disease	7.52e-06	2.63e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TP53—Alzheimer's disease	7.47e-06	2.61e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—VEGFA—Alzheimer's disease	7.34e-06	2.57e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6—Alzheimer's disease	7.25e-06	2.53e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—AKT1—Alzheimer's disease	7.24e-06	2.53e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—BCHE—Alzheimer's disease	7.17e-06	2.51e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CALM1—Alzheimer's disease	7.03e-06	2.46e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—APOE—Alzheimer's disease	7e-06	2.45e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NOS3—Alzheimer's disease	6.95e-06	2.43e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CAV1—Alzheimer's disease	6.94e-06	2.43e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6—Alzheimer's disease	6.84e-06	2.39e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	6.77e-06	2.37e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFB1—Alzheimer's disease	6.74e-06	2.36e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—AKT1—Alzheimer's disease	6.69e-06	2.34e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	6.56e-06	2.29e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	6.36e-06	2.22e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—AKT1—Alzheimer's disease	6.31e-06	2.21e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PPARG—Alzheimer's disease	6.1e-06	2.13e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—INS—Alzheimer's disease	5.98e-06	2.09e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	5.65e-06	1.98e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	5.63e-06	1.97e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TP53—Alzheimer's disease	5.55e-06	1.94e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NOS3—Alzheimer's disease	5.24e-06	1.83e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.15e-06	1.8e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6—Alzheimer's disease	5.08e-06	1.77e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—AKT1—Alzheimer's disease	4.82e-06	1.68e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—Alzheimer's disease	4.8e-06	1.68e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—AKT1—Alzheimer's disease	4.68e-06	1.64e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.63e-06	1.62e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—AKT1—Alzheimer's disease	4.42e-06	1.55e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.33e-06	1.51e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.31e-06	1.51e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.27e-06	1.49e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.76e-06	1.31e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—INS—Alzheimer's disease	3.68e-06	1.29e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.23e-06	1.13e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—AKT1—Alzheimer's disease	3.2e-06	1.12e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.96e-06	1.03e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—AKT1—Alzheimer's disease	2.41e-06	8.43e-06	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.49e-06	5.19e-06	CbGpPWpGaD
